What is the Return on Assets (ROA) of aTyr Pharma this year?
The Return on Assets (ROA) of aTyr Pharma is -0.42 undefined this year.
aTyr Pharma ROA 2024
aTyr Pharma ROA
-0.42
aTyr Pharma Dividend yield
Ticker
LIFE
ISIN
US0021202025
WKN
A2PM86
In 2024, aTyr Pharma's return on assets (ROA) was -0.42, a -11.76% increase from the -0.47 ROA in the previous year.
aTyr Pharma Aktienanalyse
What does aTyr Pharma do?
aTyr Pharma Inc is a biotechnology company based in San Diego, California. Founded in 2005, the company has gained a lot of attention in recent years for its focus on developing drugs based on proteomics, the analysis of proteins. The idea for aTyr came from the realization that there are a variety of proteins that can be used as a basis for developing new drugs. The company has developed a unique proteomics platform that allows for the identification and utilization of previously undiscovered proteins to understand biological processes and develop new drugs for diseases. aTyr specializes in the discovery and development of proteins associated with rare but difficult-to-treat diseases. This includes rare muscle diseases and lung diseases. The company collaborates closely with clinicians and scientists to advance its research and development. aTyr's business model is based on the development of new drugs based on proteomics, with a focus on rare diseases that are often neglected. The goal is to improve the quality of life for patients by developing new and innovative drugs. aTyr has various divisions, including therapeutic proteins and diagnostics. The company has a number of drugs in development targeting different diseases. This includes Resolaris, a protein focused on rare muscle diseases, and ATYR1923, developed for the treatment of lung diseases. Resolaris is a novel protein targeting rare muscle diseases such as FSHD and LGMD. It is currently being tested in clinical trials and has the potential to significantly improve the quality of life for patients with these severe conditions. The company is also developing ATYR1923, a protein for the treatment of lung diseases such as idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Overall, aTyr Pharma is an innovative company focused on the development of novel drugs based on proteomics. With its unique proteomics platform, the company has the potential to identify and utilize previously undiscovered proteins to understand biological processes and develop new drugs for diseases. With its various divisions, including therapeutic proteins and diagnostics, the company has the potential to improve the treatment of rare and difficult-to-treat diseases and enhance the lives of patients worldwide. aTyr Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding aTyr Pharma's Return on Assets (ROA)
aTyr Pharma's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing aTyr Pharma's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider aTyr Pharma's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in aTyr Pharma’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about aTyr Pharma Stock
What was the ROA of aTyr Pharma compared to the previous year?
The ROA of aTyr Pharma has increased by -11.76% compared to the previous year.
What consequences do high ROA have for investors of aTyr Pharma?
A high ROA is advantageous for investors of aTyr Pharma, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in aTyr Pharma?
A low ROA can be unfavorable for investors of aTyr Pharma as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of aTyr Pharma affect the company?
An increase in ROA of aTyr Pharma can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of aTyr Pharma impact the company?
A reduction in the ROA of aTyr Pharma can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of aTyr Pharma?
Some factors that can influence the ROA of aTyr Pharma include revenue, operating costs, asset structure, and industry average.
Why is the ROA of aTyr Pharma important for investors?
The ROA of aTyr Pharma is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can aTyr Pharma take to improve ROA?
To improve ROA, aTyr Pharma can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does aTyr Pharma pay?
Over the past 12 months, aTyr Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, aTyr Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of aTyr Pharma?
The current dividend yield of aTyr Pharma is .
When does aTyr Pharma pay dividends?
aTyr Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of aTyr Pharma?
aTyr Pharma paid dividends every year for the past 0 years.
What is the dividend of aTyr Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is aTyr Pharma located?
aTyr Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von aTyr Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of aTyr Pharma from 4/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2024.
When did aTyr Pharma pay the last dividend?
The last dividend was paid out on 4/27/2024.
What was the dividend of aTyr Pharma in the year 2023?
In the year 2023, aTyr Pharma distributed 0 USD as dividends.
In which currency does aTyr Pharma pay out the dividend?
The dividends of aTyr Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The aTyr Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von aTyr Pharma
Our stock analysis for aTyr Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of aTyr Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
